![Rosh Chandraratna](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Rosh Chandraratna is the founder of Io Therapeutics, Inc. He previously worked as the Director & Chief Scientific Officer at NuRx Pharmaceuticals, Inc. from 2007 to 2009, Vice President-Retinoid Research at Allergan, Inc. in 2004, Senior Vice President-Research & Development at Vitae Pharmaceuticals LLC from 2004 to 2006, and.
Senior Vice President-Research & Development at Acucela, Inc. in 2006 to 2007.
Actieve functies van Rosh Chandraratna
Bedrijven | Functie | Begin |
---|---|---|
Io Therapeutics, Inc.
![]() Io Therapeutics, Inc. BiotechnologyHealth Technology Io Therapeutics, Inc. develops retinoid and rexinoid molecule drugs for the treatment of cancer. The company is based in Spring, TX. The company was founded by Martin E. Sanders, Rosh Chandraratna. Martin E. Sanders has been the CEO since incorporation. | Oprichter | - |
Eerdere bekende functies van Rosh Chandraratna
Bedrijven | Functie | Einde |
---|---|---|
NURX PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | 03-10-2009 |
ACUCELA INC | Hoofd Techniek/Wetenschap/O&O | 01-05-2007 |
VITAE PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | 01-09-2006 |
ALLERGAN, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2004 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Acucela, Inc.
![]() Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
Vitae Pharmaceuticals LLC
![]() Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
NuRx Pharmaceuticals, Inc.
![]() NuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NuRx Pharmaceuticals, Inc. manufactures pharmaceutical products. It engages in treatment of cancer, chemotherapy associated neutropenia, bone marrow function, bone metabolism and lipid metabolism. The company was founded on August 14, 2001 and is headquartered in Irvine, CA. | Health Technology |
Allergan, Inc.
![]() Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Io Therapeutics, Inc.
![]() Io Therapeutics, Inc. BiotechnologyHealth Technology Io Therapeutics, Inc. develops retinoid and rexinoid molecule drugs for the treatment of cancer. The company is based in Spring, TX. The company was founded by Martin E. Sanders, Rosh Chandraratna. Martin E. Sanders has been the CEO since incorporation. | Health Technology |